Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge

Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens

Alex Y. Huang, Paul T. Golumbek, Mojgan Ahmadzadeh et al. · Science · 1994 · 1.2K citations

Life Sciences, Immunology, Oncology +17

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

José Mayordomo, Tatiana Zorina, Walter J. Storkus et al. · Nature Medicine · 1995 · 1.1K citations

Medicine, Immunology, Oncology +15

Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen

Hanspeter Pircher, Kurt Bürki, Rosemarie Lang et al. · Nature · 1989 · 1K citations

Life Sciences, Immunology, Adaptive Immunity +11

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

Laurence Zitvogel, José Mayordomo, Tjendimin Tjandrawan et al. · The Journal of Experimental Medicine · 1996 · 844 citations · Full text

Life Sciences, Immunology, Oncology +17

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.

Christina M. Celluzzi, José Mayordomo, Walter J. Storkus et al. · The Journal of Experimental Medicine · 1996 · 733 citations · Full text

Life Sciences, Immunology, Oncology +17